Specific metabolic changes observed during GLP-1 treatment include: Improved insulin sensitivity , allowing cells to use glucose more efficiently Reduced hepatic glucose production , contributing to better glycaemic control Changes in body composition , with loss of both fat mass and some lean tissue Alterations in lipid metabolism , often resulting in improved cholesterol profiles Body composition studies suggest that lean tissue loss typically accounts for approximately 20-30% of total weight lost during GLP-1 therapy, though this varies considerably between individuals and depends on concurrent physical activity and protein intake
Our mission is to make these therapies accessible to all
Is there a list of peptides and what they do PDF available
BPC-157 is a synthetic pentadecapeptide studied in connective-tissue and gut research models
Antioxidant Protection: Protects cells from oxidative damage caused by free radicals, reducing the risk of chronic diseases and supporting cellular health
Both dietary supplements are well-known fighters of oxidative stress, but there's a lot more to their benefits than just their antioxidant activity